6533b81ffe1ef96bd1277148
RESEARCH PRODUCT
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®
Bernardo Sousa-pintoPatrik E. EklundOliver PfaarLudger KlimekThorsten ZuberbierWienczyslawa CzarlewskiAnnabelle BédardCarsten Bindslev-jensenAnna BedbrookSinthia Bosnic-anticevichLuisa BrussinoVictoria CardonaÁLvaro Augusto CruzGovert De VriesPhilippe DevillierWytske Johanna FokkensJosé Miguel Fuentes-pérezBilun GemicioğluTari M.k. HaahtelaYunuen Rocío Huerta-villalobosJ. C. IvancevichInger KullP. KunaVioleta KvedarieneDésirée E.s. Larenas LinnemannDaniel LauneMichaël P. MakrisErik MelénMário A. Morais-almeidaRalph MösgesJoaquim MullolRobyn E. O'hehirN. G. PapadopoulosAna Margarida PereiraEmmanuel P. ProkopakisFotis PsarrosFrederico RegateiroSietze ReitsmaBolesław SamolinskiNicola ScichiloneJane Da SilvaCristiana StellatoA. Todo-bomPeter Valentin TomazicSanna Toppila SalmiAntonio Luís ValeroArūnas ValiulisErkka Juhani ValovirtaMichiel Van EerdM. T. VenturaArzu YorganciogluX. BasagañaJosep Maria AntóJean J. BousquetJoão Almeida Fonsecasubject
allergic rhinitisreliabilityresponsivenessRespiratory Medicine and Allergy610Public Health Global Health Social Medicine and EpidemiologyReviewallergic rhinitis; mobile health; reliability; responsiveness; visual analog scalesRC581-607Settore MED/10 - Malattie Dell'Apparato Respiratorioallergic rhinitis mobile health reliability responsiveness visual analog scalesFolkhälsovetenskap global hälsa socialmedicin och epidemiologiImmunologic diseases. Allergy[SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergologyvisual analog scalesmobile health600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und GesundheitLungmedicin och allergidescription
International audience; Background: MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Methods: Daily monitoring VAS data were assessed in MASK-air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol-5 Dimensions (EQ-5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire (work and activity impairment scores). Intra-rater reliability was assessed in users providing multiple daily VASs within the same day. Test–retest reliability was tested in clinically stable users, as defined by the EQ-5D VAS, CARAT, or “VAS Work” (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ-5D-VAS or “VAS Work” indicating clinical change. Results: A total of 17,780 MASK-air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate–high (Spearman correlation coefficient range: 0.437–0.716). Intra-rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test–retest reliability ICCs ranged between 0.604 and 0.878—“VAS Work” and “VAS asthma” presented the highest ICCs. Moderate/large responsiveness effect sizes were observed—the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness. Conclusion: In MASK-air®, daily monitoring VASs have high intra-rater reliability and moderate–high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-01-01 |